Epidural Versus Continuous Wound Ropivacaine Infusion Analgesia
CompletedNot applicableNCT01916473
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Study Hypothesis: The analgesic requirements and pain scores postoperatively differ between the epidural and continuous wound infusion techniques.
Study details
- Official title
- Epidural Versus Continuous Wound Ropivacaine Infusion: Effect on Acute and Chronic Pain After Myomectomy or Total Abdominal Hysterectomy. A Randomized Controlled Trial
- Conditions
- Postoperative Analgesia
- Interventions
- Other: Epidural analgesia
- Other: Continuous wound infusion
- Sponsor
- University of Athens
- Start date
- 2010-04
- Primary completion
- 2012-11
- Sex
- Female
- Age range
- from 25 Years to 60 Years
- Results posted
- No results posted in this snapshot
- Countries
- Greece
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: Patients ASA I-II scheduled for abdominal hysterectomy or myomectomy - Exclusion Criteria: Age older than 60 and younger than 25 years, body weight exceeding the 30% of the ideal, consumption of analgesics, sedatives, anxiolytics, antidepressants, calcium channel blockers, CNS disease or insulin dependent diabetes \-
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT01916473